PHOREMOST LIMITED

Active United Kingdom

Research and experimental development on biotechnology

45 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHOREMOST LIMITED

Research and experimental development on biotechnology

Founded 1 Apr 2014 Active United Kingdom 45 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 3 Nov 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 1 Apr 2026 Next due 15 Apr 2027 10 months remaining
Net assets £12M £2M 2024 year on year
Total assets £16M £557K 2024 year on year
Total Liabilities £4M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for PHOREMOST LIMITED (08969798), an active life sciences and medical technology company based in United Kingdom. Incorporated 1 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2015–2024)

Cash in Bank

£10.41M

Increased by £1.57M (+18%)

Net Assets

£11.74M

Increased by £1.77M (+18%)

Total Liabilities

£3.85M

Decreased by £1.22M (-24%)

Turnover

£1.57M

Increased by £520.14k (+50%)

Employees

45

Decreased by 3 (-6%)

Debt Ratio

25%

Decreased by 9 (-26%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5
Grants 1

Investors (13)

Investor NameInvestor SinceParticipating Rounds
Investor 14Mar 2015Seed
Investor 1Apr 2015Seed, Series B
Investor 2Apr 2015Seed

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 1,107,165 Shares £52.35m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Dec 20259,118£455.9£0.05
17 Dec 2025185£107.3£0.58
5 Feb 202534,555£2k£0.05
5 Feb 202531,639£18k£0.58
30 Aug 2024329,250£5.00m£15.186

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (56)

Mnl (parkwalk) Nominees Limited (as Nominee For Parkwalk Funds)
12.0%
795,800
Bgf Nominees Limited As Nominee Of Bgf Investments Lp
8.4%
559,730

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Christopher John Torrance

Ceased 23 Feb 2017

Ceased

Professor Ashok Venkitaraman

Ceased 23 Feb 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Suite 3 and 7, The Works, Unity Campus, London Road, Sawston, Cambridge SOUTH CAMBRIDGESHIRE
Leasehold-18 Jun 2021
Suite 3 and 7, The Works, Unity Campus, London Road, Sawston, Cambridge
Leasehold
Added 18 Jun 2021
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
8 May 2026AddressChange Registered Office Address Company With Date Old Address New Address
20 Apr 2026CapitalAllotment of shares (GBP 665.52) on 8 Apr 2026
1 Apr 2026Confirmation StatementConfirmation statement made on 1 Apr 2026 with updates
16 Mar 2026CapitalAllotment of shares (GBP 665.1044) on 6 Jan 2026
13 Feb 2026OfficersTermination of Jonathan Simon Milner as director on 4 Feb 2026
8 May 2026 Address

Change Registered Office Address Company With Date Old Address New Address

20 Apr 2026 Capital

Allotment of shares (GBP 665.52) on 8 Apr 2026

1 Apr 2026 Confirmation Statement

Confirmation statement made on 1 Apr 2026 with updates

16 Mar 2026 Capital

Allotment of shares (GBP 665.1044) on 6 Jan 2026

13 Feb 2026 Officers

Termination of Jonathan Simon Milner as director on 4 Feb 2026

Recent Activity

Latest Activity

Change Registered Office Address Company With Date Old Address New Address

4 weeks ago on 8 May 2026

Allotment of shares (GBP 665.52) on 8 Apr 2026

1 months ago on 20 Apr 2026

Confirmation statement made on 1 Apr 2026 with updates

2 months ago on 1 Apr 2026

Allotment of shares (GBP 665.1044) on 6 Jan 2026

2 months ago on 16 Mar 2026

Termination of Jonathan Simon Milner as director on 4 Feb 2026

3 months ago on 13 Feb 2026